Literature DB >> 24940112

Hormonal manipulation with letrozole in the treatment of metastatic malignant pecoma.

P Le1, A Garg1, G Brandao2, A Abu-Sanad1, L Panasci1.   

Abstract

Perivascular epithelioid cell tumours (pecomas) are rare mesenchymal tumours. Some have a benign course; others metastasize. Treatment of malignant pecomas is challenging, and little is known about treatment for patients with metastatic disease. Here, we report a case of metastatic malignant pecoma with estrogen and progesterone receptor expression that showed a favourable and sustained response to letrozole.

Entities:  

Keywords:  Malignant pecoma; estrogen; letrozole; metastasis; pecoma; progesterone; receptors; sirolimus

Year:  2014        PMID: 24940112      PMCID: PMC4059816          DOI: 10.3747/co.21.1849

Source DB:  PubMed          Journal:  Curr Oncol        ISSN: 1198-0052            Impact factor:   3.677


  15 in total

Review 1.  The tuberous sclerosis complex.

Authors:  Peter B Crino; Katherine L Nathanson; Elizabeth Petri Henske
Journal:  N Engl J Med       Date:  2006-09-28       Impact factor: 91.245

2.  Pulmonary lymphangiomyomatosis. Follow-up and long-term outcome with antiestrogen therapy; a report of eight cases.

Authors:  T Urban; F Kuttenn; A Gompel; J Marsac; J Lacronique
Journal:  Chest       Date:  1992-08       Impact factor: 9.410

Review 3.  Perivascular epithelioid cell neoplasms of soft tissue and gynecologic origin: a clinicopathologic study of 26 cases and review of the literature.

Authors:  Andrew L Folpe; Thomas Mentzel; Hans-Anton Lehr; Cyril Fisher; Bonnie L Balzer; Sharon W Weiss
Journal:  Am J Surg Pathol       Date:  2005-12       Impact factor: 6.394

4.  [Lymphangioleiomyomatosis: new therapeutic approaches].

Authors:  Alvaro Casanova; Julio Ancochea
Journal:  Arch Bronconeumol       Date:  2011-09-15       Impact factor: 4.872

5.  Efficacy of oophorectomy in lymphangioleiomyomatosis and benign metastasizing leiomyoma.

Authors:  A S Banner; C B Carrington; W B Emory; F Kittle; G Leonard; J Ringus; P Taylor; W W Addington
Journal:  N Engl J Med       Date:  1981-07-23       Impact factor: 91.245

6.  Pulmonary lymphangioleiomyomatosis and steroid receptors. An immunocytochemical study.

Authors:  U Berger; A Khaghani; A Pomerance; M H Yacoub; R C Coombes
Journal:  Am J Clin Pathol       Date:  1990-05       Impact factor: 2.493

7.  Efficacy of hormonal manipulation in lymphangioleiomyomatosis. A 20-year-experience in 36 patients.

Authors:  Mario Schiavina; Paola Contini; Andrea Fabiani; Franca Cinelli; Valerio Di Scioscio; Maurizio Zompatori; Cristina Campidelli; Stefano A Pileri
Journal:  Sarcoidosis Vasc Diffuse Lung Dis       Date:  2007-03       Impact factor: 0.670

8.  Estrogen promotes the survival and pulmonary metastasis of tuberin-null cells.

Authors:  Jane J Yu; Victoria A Robb; Tasha A Morrison; Eric A Ariazi; Magdalena Karbowniczek; Aristotelis Astrinidis; Chunrong Wang; Lisa Hernandez-Cuebas; Laura F Seeholzer; Emmanuelle Nicolas; Harvey Hensley; V Craig Jordan; Cheryl L Walker; Elizabeth P Henske
Journal:  Proc Natl Acad Sci U S A       Date:  2009-02-06       Impact factor: 11.205

9.  Response to treatment with an analog of the luteinizing-hormone-releasing hormone in a patient with pulmonary lymphangioleiomyomatosis.

Authors:  G A Rossi; B Balbi; S Oddera; S Lantero; C Ravazzoni
Journal:  Am Rev Respir Dis       Date:  1991-01

10.  "Malignant" perivascular epithelioid cell neoplasm: risk stratification and treatment strategies.

Authors:  Jonathan S Bleeker; J Fernando Quevedo; Andrew L Folpe
Journal:  Sarcoma       Date:  2012-04-26
View more
  3 in total

1.  Spectrum of Presentations and Management Strategies in Renal Angiomyolipoma.

Authors:  Sinan Khaddam; Shuchi Gulati
Journal:  J Kidney Cancer VHL       Date:  2022-01-28

2.  PEComa of the Uterus: A Rare Mesenchymal Tumor Displaying a ≪Snowstorm≫ Pattern at Magnetic Resonance Imaging.

Authors:  N Verbeeck; A Toukouki; R Weis; D Van Wymersch
Journal:  J Belg Soc Radiol       Date:  2016-01-29       Impact factor: 1.894

3.  Feasibility and Long-Term Efficacy of PEComa Treatment-20 Years of Experience.

Authors:  Aleksandra Sobiborowicz; Tomasz Świtaj; Paweł Teterycz; Mateusz J Spałek; Anna Szumera-Ciećkiewicz; Michał Wągrodzki; Marcin Zdzienicki; Anna M Czarnecka; Piotr Rutkowski
Journal:  J Clin Med       Date:  2021-05-19       Impact factor: 4.241

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.